No abstract

Many acutely unwell, hospitalized patients receive continuous intravenous (IV) fluids. Complications of IV fluid administration include electrolyte abnormalities and fluid overload, which be detected by appropriate IV fluid administration and monitoring practices. This prospective clinical audit described the administration and monitoring of maintenance IV fluid in ward patients in an Australian tertiary teaching hospital. Of 332 inpatients (98%), 85 (26%) were receiving IV fluids. Serum electrolyte and renal function measurements were obtained in 85% versus 65% of patients receiving IV fluids versus no IV fluids (P < 0.001). Fluid balance charts were being maintained for 94% versus 44% of patients receiving IV fluids versus no IV fluids (P < 0.001). Body weight measurements were documented for 15% versus 14% for patients receiving IV fluids versus no IV fluids (P = 0.078). Findings show that approximately one-quarter of adult ward patients in our hospital received IV fluids. Monitoring of such patients using regular blood tests and fluid balance charts is high, but patient weight measurements are low. Why hospitalized patients who require maintenance IV fluids do not have regular body weight measurements requires further investigation.

Background Many clinical interventions are trialled to manage medical complications following Traumatic Brain Injury (TBI). However, published evidence for the effects of those clinical interventions is limited. This article is an overview of common complications and their management from published systematic reviews in TBI. Methods and findings A health science electronic database search for published systematic reviews for management of common complications in TBI was conducted in the last decade till 31st January 2021. Methodological quality and evidence were critically appraised using the Grading of Recommendations, Assessment, Development and Evaluations and Revised-Assessment of Multiple Systematic review tools. Overall, only six systematic reviews complied with search criteria, these evaluated fatigue, spasticity and post traumatic seizures (29 RCTs, 13 cohort studies, n = 5639 participants). No systematic reviews for other common TBI-related complications met criteria for this review. The included reviews varied from ‘moderate to high’ in methodological quality. The findings suggest beneficial treatment effect of anti-epileptic drugs (phenytoin/levetiracetam) compared with placebo in reducing early seizure incidence, but no significant benefit of phenytoin over levetiracetam, valproate, or neuroprotective agent for early or late posttraumatic seizures. There was ‘limited’ evidence for spasticity-related interventions, and ‘insufficient’ evidence of cardiorespiratory training on fatigue levels. Conclusions Despite the high prevalence and associated functional impact of TBI-related complications, there is limited evidence to guide treating clinicians for management of common TBI complications. More robust studies are needed to build evidence in this population.

No abstract